Hypothalamic supraoptic but not paraventricular nucleus is involved in cardiovascular responses to carbachol microinjected into the bed nucleus of stria terminalis of unanesthetized rats  by Alves, Fernando H.F. et al.
B R A I N R E S E A R C H 1 3 9 3 ( 2 0 1 1 ) 3 1 – 4 3
ava i l ab l e a t www.sc i enced i r ec t . com
www.e l sev i e r . com/ loca te /b ra i n resResearch Report
Hypothalamic supraoptic but not paraventricular nucleus is
involved in cardiovascular responses to carbacholmicroinjected
into the bed nucleus of stria terminalis of unanesthetized ratsFernando H.F. Alvesa,⁎,1, Carlos C. Crestanib,1, Cristiane Busnardoa,1,
José Antunes-Rodriguesc, Felipe V. Gomesa, Leonardo B.M. Resstela, Fernando M.A. Corrêaa
aDepartment of Pharmacology, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil
bDepartment ofNatural Active Principles andToxicology, School of Pharmaceutical Sciences, São Paulo StateUniversity, UNESP,Araraquara, SP, Brazil
cDepartment of Physiology, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, BrazilA R T I C L E I N F O⁎ Corresponding author at: University of São P
3900, 14049–900, Ribeirão Preto, São Paulo, B
E-mail address: fer_farmacia@yahoo.com
Abbreviations: aCSF, Artificial cerebrospina
rate; MAP, Mean arterial pressure; PAP, Puls
nucleus of the hypothalamus
1 The authors contributed equally to this w
0006-8993 © 2011 Elsevier B.V.
doi:10.1016/j.brainres.2011.03.067
Open access under A B S T R A C TArticle history:
Accepted 29 March 2011
Available online 3 April 2011Microinjection of the cholinergic agonist carbachol into the bed nucleus of the stria terminalis
(BST) has been reported to cause pressor response in unanesthetized rats,whichwas shown to
be mediated by an acute release of vasopressin into the systemic circulation and followed by
baroreflex-mediated bradycardia. In the present study, we tested the possible involvement of
the hypothalamic paraventricular (PVN) and supraoptic (SON) nuclei in the pressor response
evoked by carbachol microinjection into the BST of unanesthetized rats. For this,
cardiovascular responses following carbachol (1 nmol/100 nL) microinjection into the BST
were studied before and after PVN or SON pretreatment, either ipsilateral or contralateral in
relation to BST microinjection site, with the nonselective neurotransmission blocker cobalt
chloride (CoCl2, 1 mM/100 nL). Carbacholmicroinjection into the BST evokedpressor response.
Moreover, BST treatment with carbachol significantly increased plasma vasopressin levels,
thus confirming previous evidences that carbacholmicroinjection into the BST evokes pressor
response due to vasopressin release into the circulation. SON pretreatment with CoCl2, either
ipsilateral or contralateral in relation to BSTmicroinjection site, inhibited the pressor response
to carbachol microinjection into the BST. However, CoCl2 microinjection into the ipsilateral or
contralateral PVN did not affect carbachol-evoked pressor response. In conclusion, our results
suggest that pressor response to carbachol microinjection into the BST is mediated by SON
magnocellular neurons, without significant involvement of those in the PVN. The results also
indicate that responses to carbachol microinjection into the BST are mediated by a neural
pathway that depends on the activation of both ipsilateral and contralateral SON.
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32 B R A I N R E S E A R C H 1 3 9 3 ( 2 0 1 1 ) 3 1 – 4 31. IntroductionThe bed nucleus of the stria terminalis (BST) is a structure of
the limbic system that is involved in behavioral, neuroendo-
crine and autonomic responses (Alves et al., 2007; Crestani et
al., 2007, 2008a; Dunn and Williams, 1995). Moreover, it has
been proposed that the BST is an important center for the
regulation of cardiovascular activity (Crestani et al., 2009a;
Gelsema et al., 1987; Ulrich-Lai andHerman, 2009). The electric
stimulation of the BST has been reported to evoke pressor as
well as depressor responses in anesthetized rats (Dunn and
Williams, 1995). Cardiovascular responses was also observed
after chemical stimulation of the BST using either glutamate,
D,L-homocysteic acid or noradrenaline (Ciriello and Janssen,
1993; Crestani et al., 2007; Gelsema et al., 1987, 1993; Hatam
and Nasimi, 2007). In addition, there is evidence that the BST
tonically modulates cardiac baroreflex activity (Alves et al.,
2009; Crestani et al., 2006, 2008b; Li and Dampney, 1994;
McKitrick et al., 1992).
Cholinergic synaptic terminals as well as muscarinic and
nicotinic cholinergic receptors have been identified in the BST
(Clarke et al., 1985; Ruggiero et al., 1990; Wamsley et al., 1984),
thus providing evidence of a cholinergic neurotransmission in
the BST. We have previously reported that microinjection of
carbachol, a cholinergic agonist, into the BST of unanesthe-
tized rats caused an increase in arterial pressure that was
followed by a baroreflex-mediated reduction of the heart rate
(HR) (Alves et al., 2007). These responses were inhibited by
systemic pretreatment with a V1-vasopressinergic receptor
antagonist (Alves et al., 2007), thus suggesting a mediation by
acute vasopressin release into the systemic circulation.
Moreover, cardiovascular responses to carbachol microinjec-
tion into the BST were mediated by activation of local M2-
cholinergic receptors (Alves et al., 2007). These results
suggested the existence of a cholinergic mechanism in the
BST that integrates cardiovascular and neuroendocrine con-
trol and could take part in fluid balance adjustments.
However, the neural pathway involved in cardiovascular
responses to carbachol microinjection into the BST is yet
unknown.
Vasopressin, also known as antidiuretic hormone, is a
nonapeptide with a potent vasoconstrictor action (Altura and
Altura, 1984; Barer, 1961). This peptide is synthesized by
magnocellular neurons located in the paraventricular (PVN)
and supraoptic (SON) nuclei of the hypothalamus and stored
in the posterior hypophysis to further release into the
systemic circulation (Swaab et al., 1975). Because cardiovas-
cular responses following carbachol microinjection into the
BST were shown to be mediated by an acute release of
vasopressin into the systemic circulation (Alves et al., 2007),
the magnocellular neurons in the SON and/or PVN must be
involved in their mediation. Considering this, it is relevant to
study which hypothalamic magnocellular nucleus mediates
the cardiovascular response evoked by carbachol microinjec-
tion into the BST.
Taking that into consideration, we evaluated the hypoth-
esis that PVN and/or SON neurons are part of the neural
pathway related to cardiovascular responses following carba-
chol microinjection into the BST of unanesthetized rats. Forthis, we investigated cardiovascular responses evoked by
carbachol microinjection into the BST before and after PVN
or SON pretreatment, either ipsilateral or contralateral in
relation to BST microinjection site, with the nonselective
neurotransmission blocker cobalt chloride (CoCl2).2. Results
2.1. Cardiovascular responses to aCSF or carbachol
microinjection into the bed nucleus of the stria terminalis of
unanesthetized rats
Microinjection of aCSF into the BST (n=5) did not affect either
MAP (99±2 vs. 98±3 mmHg, t=0.2, P>0.05) or HR (379±11 vs.
352±9 bpm, t=1.3, P>0.05) baseline values. However, micro-
injection of carbachol into the BST caused significant pressor
and bradycardiac responses in unanesthetized rats (Fig. 1).
Photomicrography of a coronal brain section showing a
representative microinjection site into the BST is presented in
Fig. 2. Diagrammatic representation of the BST indicating
microinjection sites into the BST of all animals used in the
present study is also shown in Fig. 2.
2.2. Effect of aCSF or carbachol microinjection into the bed
nucleus of the stria terminalis in plasma vasopressin levels
Microinjection of carbachol (n=6) into the BST significantly
increased plasma vasopressin content (aCSF: 2.3±0.5 pg/mL
vs. carbachol: 21.3±3.6 pg/mL, t=5, P<0.005), when compared
to the control group that received vehicle (aCSF) injection into
the BST (n=6).
2.3. Effect of supraoptic nucleus pretreatment with aCSF or
CoCl2 in cardiovascular responses to carbachol microinjection
into the bed nucleus of the stria terminalis
2.3.1. Ipsilateral supraoptic nucleus
Microinjection of aCSF into the ipsilateral SON (n=7) did not
affect either MAP (98±2 vs. 101±3 mmHg, t=0.5, P>0.05) or HR
(352±7 vs. 367±11 bpm, t=1.5, P>0.05) baseline values.
Pretreatment of the ipsilateral SON with aCSF also did not
affect the pressor (43±2 vs. 38±2 mmHg, t=2.3, P>0.05) and
bradycardiac (−67±7 vs. −64±8 bpm, t=0.2, P>0.05) response
to carbachol microinjection into the BST (Fig. 1A).
Microinjection of CoCl2 into the ipsilateral SON (n=7) did
not affect either MAP (102±2 vs. 100±2 mmHg, t=0.6, P>0.05)
or HR (351±6 vs. 356±8 bpm, t=0.7, P>0.05) baseline values.
However, ipsilateral SON pretreatment with CoCl2 significant-
ly reduced the pressor (44±2 vs. 6±1 mmHg, t=16, P<0.0001)
and bradycardiac (−74±6 vs. −12±1 bpm, t=10, P<0.0001)
response to carbachol microinjection into the BST (Fig. 1A).
Time-course analysis indicated a significant effect of SON
pretreatment with CoCl2 in carbachol cardiovascular effects
(ΔMAP: F(1,456)=468, P<0.0001 and ΔHR: F(1,456)=111, P<0.0001),
a significant effect over time (ΔMAP: F(37,456)=23, P<0.0001 and
ΔHR: F(37,456)=11, P<0.0001), and an interaction between
treatment and time (ΔMAP: F(37,456)=20, P<0.0001 and ΔHR:
F(37,456)=4, P<0.0001) (Fig. 1B).
Fig. 1 – A) Changes in MAP (ΔMAP) and HR (ΔHR) in response to carbachol (CBH; 1 nmol/100 nL) microinjection into the BST before
(filledcolumns) andafter (open columns)pretreatmentof ipsilateral or contralateral SON, in relation toBSTmicroinjectionsite,with
vehicle (aCSF) or CoCl2 (cobalt). Columns represent the mean and bars the SEM. *P<0.05, paired Student's t-test. B) Time-course of
the effect of CBHmicroinjection into the BST onMAP and HR before (filled circles) or after (open circles) pretreatment of the
ipsilateral SON (left) or contralateral SON (right)withCoCl2. CBH injectionsweremadeat time 0. Circles represent themean andbar
the SEM. Data were analyzed using two-way ANOVA.
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Microinjection of aCSF into the contralateral SON (n=6) did not
affect either MAP (100±3 vs. 102±4 mmHg, t=0.5, P>0.05) or
HR (353±11 vs. 372±6 bpm, t=1.6, P>0.05) baseline values.Pretreatment of the contralateral SON with aCSF also did not
affect both the pressor (44±4 vs. 37±3 mmHg, t=2.2, P>0.05)
and bradycardiac (−67±8 vs. −74±8 bpm, t=0.5, P>0.05)
response to carbachol microinjection into the BST (Fig. 1A).
Fig. 2 – A) Photomicrograph of a coronal brain section showing a microinjection site in the BST of one representative animal.
B) Diagrammatic representation, modified from the rat brain atlas of Paxinos andWatson (1997), indicating carbachol and
aCSFmicroinjection sites into the BST. ac, anterior commissure; f, fornix; IA, interaural coordinates (mm); ic, internal capsule; LSV,
lateral septal ventricle; LV, lateral ventricle; PS, parastrial nuclei; and st, stria terminalis.
34 B R A I N R E S E A R C H 1 3 9 3 ( 2 0 1 1 ) 3 1 – 4 3Microinjection of CoCl2 into the contralateral SON (n=6) did
not affect either MAP (101±3 vs. 100±4 mmHg, t=0.1, P>0.05)
or HR (362±9 vs. 359±10 bpm, t=0.3, P>0.05) baseline values.
However, contralateral SON pretreatment with CoCl2 signifi-
cantly reduced the pressor (42±5 vs. 9±2 mm Hg, t=5,
P<0.005) and bradycardiac (−74±6 vs. −13±2 bpm, t=10,
P<0.0001) response to carbachol microinjection into the BST
(Fig. 1A). Time-course analysis indicated a significant effect of
SON pretreatment with CoCl2 in carbachol cardiovascular
effects (ΔMAP: F(1,380)=215, P<0.0001 and ΔHR: F(1,380)=141,
P<0.0001), a significant effect over time (ΔMAP: F(37,380)=16,
P<0.0001 and ΔHR: F(37,380)=8, P<0.0001), and an interaction
between treatment and time (ΔMAP: F(37,380)=11, P<0.0001 and
ΔHR: F(37,380)=3, P<0.0001) (Fig. 1B). Cardiovascular responses
to carbachol microinjection into the BST of animals that
received CoCl2 in the ipsilateral or contralateral SON were not
significantly different (MAP: t=2, P>0.05; HR: t=1, P>0.05)
(Fig. 1).
Representative recordings showing the cardiovascular re-
sponses to carbachol microinjection into the BST before andafter ipsilateral or contralateral SON pretreatment with CoCl2 is
presented in Fig. 3. Moreover, photomicrography of coronal
brain section showing the microinjection site in the ipsilateral
and contralateral SON of representative animals are presented
in Figs. 4 and 5, respectively. Diagrammatic representation
showingmicroinjection sites of CoCl2 and aCSF in the ipsilateral
andcontralateralSONisalso showninFigs. 4 and5, respectively.
2.4. Effect of paraventricular nucleus pretreatment with
aCSF or CoCl2 in cardiovascular responses to carbachol
microinjection into the bed nucleus of the stria terminalis
2.4.1. Ipsilateral paraventricular nucleus
Microinjection of aCSF into the ipsilateral PVN (n=7) did not
affect either MAP (99±3 vs. 102±2 mmHg, t=0.6, P>0.05) or HR
(357±7 vs. 364±10 bpm, t=0.5, P>0.05) baseline values.
Ipsilateral PVN treatment with aCSF also did not affect the
pressor (43±3 vs. 40±2 mmHg, t=0.7, P>0.05) and bradycar-
diac (−78±6 vs. −73±5 bpm, t=0.8, P>0.05) response following
carbachol microinjection into the BST (Fig. 6A).
Fig. 3 – Typical recordings showing pulsatile arterial pressure (PAP),mean arterial pressure (MAP) and heart rate (HR) changes in
response to carbachol (CBH; 1 nmol/100 nL) microinjection into the BST of unanesthetized rats before (before cobalt) and after
(after cobalt) pretreatment of ipsilateral or contralateral SON, in relation to BST microinjection site, with CoCl2. The panels
represent segments of recording in different animals.
35B R A I N R E S E A R C H 1 3 9 3 ( 2 0 1 1 ) 3 1 – 4 3Microinjection of CoCl2 into the ipsilateral PVN (n=7) did
not affect either MAP (99±3 vs. 100±3 mmHg, t=0.8, P>0.05)
or HR (366±9 vs. 374±9 bpm, t=0.5, P>0.05) baseline values.
Moreover, ipsilateral PVN pretreatment with CoCl2 did not
affect the pressor (41±3 vs. 38±2 mmHg, t=0.9, P>0.05) and
bradycardiac (−76±8 vs. −73±6 bpm, t=0.3, P>0.05) response
to carbacholmicroinjection into the BST (Fig. 6A). Time-course
analysis did not show a significant effect of PVN pretreatment
with CoCl2 in carbachol cardiovascular responses (ΔMAP:
F(1,456)=2, P>0.05; ΔHR: F(1,456)=2, P>0.05), but indicated a
significant effect over time on the MAP (F(37,456) = 45,
P<0.0001) and HR (F(37,456)=18, P<0.0001) (Fig. 6B).
2.4.2. Contralateral paraventricular nucleus
Microinjection of aCSF into the contralateral PVN (n=6) did not
affect either MAP (101±3 vs. 98±2 mmHg, t=0.5, P>0.05) or HRFig. 4 – A) Photomicrograph of a coronal brain section showing a
microinjection site, of one representative animal. B) Diagramma
Paxinos and Watson (1997), indicating aCSF (open circles) and Co
SON. IA, interaural coordinates (mm); LH, lateral hypothalamus;(353±11 vs. 361±7 bpm, t=0.5, P>0.05) baseline values.
Contralateral PVN treatment with aCSF also did not affect
the pressor (43±4 vs. 39±3 mm Hg, t=0.8, P>0.05) and
bradycardiac (−76±9 vs. −68±6 bpm, t=0.8, P>0.05) response
to carbachol microinjection into the BST (Fig. 6A).
Microinjection of CoCl2 into the contralateral PVN (n=6)
did not affect either MAP (99±3 vs. 104±4 mm Hg, t=1.5,
P>0.05) or HR (359 ± 9 vs. 372± 12 bpm, t = 0.9, P>0.05)
baseline values. Moreover, contralateral PVN pretreatment
with CoCl2 did not affect the pressor (42±4 vs. 41±2 mm Hg,
t=0.1, P>0.05) and bradycardiac (−70±9 vs. −65±8 bpm,
t=0.5, P>0.05) response to carbachol microinjection into the
BST (Fig. 6A). Time-course analysis did not show a signifi-
cant effect of contralateral PVN pretreatment with CoCl2 in
carbachol cardiovascular responses (ΔMAP: F(1,380) = 2,
P>0.05; ΔHR: F(1,380) =0.2, P>0.05) (Fig. 6B), but indicated amicroinjection site in the ipsilateral SON, in relation to BST
tic representation, modified from the rat brain atlas of
Cl2 (filled black circles) microinjection sites in the ipsilateral
and ox, optic chiasm.
Fig. 5 – A) Photomicrograph of a coronal brain section showing a microinjection site in the contralateral SON, in relation to
BST microinjection site, of one representative animal. B) Diagrammatic representation, modified from the rat brain atlas of
Paxinos andWatson (1997), indicating aCSF (open circles) and CoCl2 (filled black circles) microinjection sites in the contralateral
SON. IA, interaural coordinates (mm); LH, lateral hypothalamus; and ox, optic chiasm.
36 B R A I N R E S E A R C H 1 3 9 3 ( 2 0 1 1 ) 3 1 – 4 3significant effect over time on the MAP (F(37,380) = 44,
P<0.0001) and HR (F(37,380) =11, P<0.0001).
Photomicrography of coronal brain section showing the
microinjection site in the ipsilateral and contralateral PVN of
representative animals is presented in Figs. 7 and 8, respec-
tively. Diagrammatic representation showing microinjection
sites of CoCl2 and aCSF in the ipsilateral and contralateral PVN
is also shown in Figs. 7 and 8, respectively.3. Discussion
The BST is localized in the rostral prosencephalon, and is
associated with autonomic and neuroendocrine functions
(Dunn, 1987; Dunn andWilliams, 1995; Ulrich-Lai andHerman,
2009). Cholinergic synaptic terminals were indentified in the
BST (Ruggiero et al., 1990). Moreover, binding studies described
the presence of muscarinic and nicotinic receptors in the BST
(Clarke et al., 1985; Wamsley et al., 1984). Electrophysiological
studies reported that BST neurons showed an increase in
firing rate in response to local administration of acetylcholine
through activation of local muscarinic cholinergic receptors
(Casada and Dafny, 1993a, 1993b). We have previously
reported that microinjection of carbachol, a cholinergic
agonist, into the BST of unanesthetized rats evoked a pressor
response that was followed by a baroreflex-mediated brady-
cardia (Alves et al., 2007). These cardiovascular effects were
blocked after local pretreatment with an M2-muscarinic
receptor antagonist as well as after systemic pretreatment
with a V1-vasopressinergic receptor antagonist (Alves et al.,
2007), thus suggesting that activation of M2-muscarinic
receptor activation within BST evokes cardiovascular changes
that are mediated by acute vasopressin release into thecirculation. In the present study, we show results indicating
that carbachol microinjection into the BST increases circulat-
ing vasopressin levels, thus confirming previous evidence that
carbachol microinjection into the BST evokes pressor re-
sponse due to vasopressin release.
Vasopressin is a potent vasoconstrictor agent (Altura and
Altura, 1984; Barer, 1961). This nonapeptide is synthesized by
magnocellular neurons of the PVN and SON (Swaab et al., 1975).
Each neuron gives rise to a single axon into the posterior
pituitary gland, where its neurosecretory endings release
vasopressin (Swaab et al., 1975). Because the capillaries within
the pituitary gland do not have a blood-brain barrier, vasopres-
sin released in closeproximity to the capillaries easily enters the
bloodstream (Leng et al., 1999). To verify if SON and/or PVN
synapses mediate the pressor response to the carbachol
microinjection into the BST, we pretreated both nuclei with
the nonselective neurotransmission blocker CoCl2. The use of
CoCl2 is a common approach to investigate a possible involve-
ment of specific brain areas in a functional neural pathway. The
technique is based on the administration of circumscribed
microinjections of compounds that reversibly block neuronal
activity over a given period of time. Themicroinjection of CoCl2
into discrete brain areas has been used for the functional
inactivation of synapses (Crestani et al., 2006, 2009b; Giancola et
al., 1993; Scopinho et al., 2008). The CoCl2 reduces presynaptic
Ca+2 influx, leading to an inhibition of neurotransmitter release
and a consequent synaptic blockade (Kretz, 1984), without
influence on passage fibers. The inhibition caused by this
compound, whenmicroinjected in volumes and concentrations
that were similar to those presently used, was reported to
spread over an area up to 1 mm2 (Lomber, 1999).
Pretreatment of the PVN with CoCl2, either injected
ipsilateral or contralateral in relation to BST microinjection
Fig. 6 –A) Changes inMAP (ΔMAP) andHR (ΔHR) in response to carbachol (CBH; 1 nmol/100 nL)microinjection into the BST before
(filled columns) and after (open columns) pretreatment of the ipsilateral and contralateral PVN, in relation to BSTmicroinjection
site, with vehicle (aCSF) or CoCl2 (cobalt). Columns represent the mean and bars the SEM. *P<0.05, paired Student's t-test. B)
Time-course of the effect of CBH microinjection into the BST on MAP and HR before (filled circles) or after (open circles)
pretreatment of the ipsilateral or contralateral PVNwith CoCl2. CBH injections were made at time 0. Circles represent the mean
and bar the SEM. Data were analyzed using two-way ANOVA.
37B R A I N R E S E A R C H 1 3 9 3 ( 2 0 1 1 ) 3 1 – 4 3site, did not affect the cardiovascular response to the
microinjection carbachol into the BST. The absence of effect
was not due to an insufficient dose of CoCl2, because inprevious studies it has been reported that the microinjection
of such dose into the PVNwas effective to inhibit vasopressin-
mediated pressor responses observed after the injection of
Fig. 7 – A) Photomicrograph of a coronal brain section showing a microinjection site in the ipsilateral PVN, in relation to
BSTmicroinjection site, of one representative animal. B) Diagrammatic representationmodified from the rat brain atlas of Paxinos
andWatson (1997), indicating aCSF (open circles) and CoCl2 (filled black circles)microinjection sites in the ipsilateral PVN. 3V, third
ventricle; IA, interaural coordinates (mm); LH, lateral hypothalamus; ox, optic chiasm; and sox, supraoptic decussation.
38 B R A I N R E S E A R C H 1 3 9 3 ( 2 0 1 1 ) 3 1 – 4 3noradrenaline into either the BST or the lateral septal area
(Crestani et al., 2009b; Scopinho et al., 2008). Pretreatment of
either the ipsilateral or the contralateral SON with CoCl2
blocked the pressor and bradycardiac responses caused by the
microinjection carbachol into the BST. Together, these results
suggest that synapses in the SON, but not in the PVN, mediate
the cardiovascular responses to the microinjection of carba-
chol into the BST.
There is neuroanatomic evidence that the BST projects to
the SON and that such projections aremainly ipsilateral (Dong
and Swanson, 2003, 2004, 2006). The existence of bilateral
neural connections between the two SON was suggested by
electrophysiological and in vivo studies, thus supporting our
results that both SON are involved in the mediation of the
cardiovascular response to the microinjection of carbachol
into the BST. Takano et al. (1990) reported that one-third of the
vasopressin-containing neurons tested in the SON were
excited by electric stimulation of the contralateral SON. In
the same study, those authors reported that vasopressin
neurons tested in the SON were not antidromically activated
by a contralateral SON stimulation, thus suggesting that
neural connections between the bilateral SON are mainly
polysynaptic. It was also reported that antidiuretic effect
associated with noradrenaline microinjection into the SON
was inhibited either by a lesion of the contralateral SON or its
pretreatment with adrenoceptor antagonists (Tsushima et al.,
1996), indicating the existence of bilateral adrenergic neuralconnections between supraoptic nuclei. Because the pressor
response to the microinjection of carbachol into the BST was
inhibited by the blockade of either the ipsilateral or the
contralateral SON, it is possible that carbachol administration
into the BST activates a pathway from the BST to the
ipsilateral SON, in relation to BST microinjection site, which
would stimulate neuron(s) that project to contralateral SON,
thus suggesting that carbachol responses would depend on a
bilateral SON cross-talking. Therefore, activation of vasopres-
sinergic neurons in the contralateral SON in relation to BST
stimulation site would mediate pressor response to carbachol
administration into the BST. A schematic representation
sketching the mechanism by which carbachol microinjection
into the BST evokes a vasopressin-mediated pressor response
is presented in Fig. 9.
The pathway for the neural connection between bilateral
SON is not totally understood. Moos and Richard (1989)
concluded that the supraventricular gray commissura is
important for interconnection of oxytocin-containing neurons
in the SON, because synchronization of oxytocin-containing
neurons in the bilateral SON disappeared after an inter
hemisphere sectioning (including the supraventricular gray
commissura and the corpus callosum), but persisted after a
superficial interhemisphere sectioning that was limited to the
corpus callosum. Therefore, the supraventricular gray com-
missura is a possible pathway for interconnections between
bilateral SON vasopressin-containing neurons. Also, other
Fig. 8 – A) Photomicrograph of a coronal brain section showing a microinjection site in the contralateral PVN, in relation to
BSTmicroinjectionsite, of one representative animal. B)Diagrammatic representation,modified fromthe rat brainatlas of Paxinos
andWatson (1997), indicating aCSF (open circles) and CoCl2 (filled black circles) microinjection sites in the contralateral PVN. 3V,
third ventricle; IA, interaural coordinates (mm); LH, lateral hypothalamus; ox, optic chiasm; and sox, supraoptic decussation.
Fig. 9 – Schematic representation illustrating the proposed
mechanism by which carbachol (CBH) microinjection into
the BST evokes vasopressin release. ac— anterior commissure,
AVP— vasopressin, CBH— carbachol, and M2— subtype
M2 of cholinergic muscarinic receptor.
39B R A I N R E S E A R C H 1 3 9 3 ( 2 0 1 1 ) 3 1 – 4 3connections between bilateral supraoptic nuclei, through the
medulla oblongata and pons, have been suggested to exist
(Tsushima et al., 1996), thus indicating alternative pathways
for a bilateral SON cross-talking.
It has been reported that the microinjection of noradren-
aline into the BST also evoked pressor response that was
mediated by an acute release of vasopressin into the
circulation (Crestani et al., 2007). This response was blocked
by PVN pretreatment with CoCl2 and not affected by SON
blockade (Crestani et al., 2009b), thus suggesting a major
involvement of PVN magnocellular neurons without any
significant involvement of neurons in the SON. The present
study led to the interesting observation that BST noradrener-
gic and cholinergic neurotransmissionsmodulate vasopressin
release into the circulation through different neural pathways.
This modulation of the vasopressin release by BST noradren-
ergic and cholinergic neurotransmission through specific
neural pathway may have a physiological importance, since
BST neurons can stimulate vasopressin release through local
cholinergic receptor despite of changes in pathway related to
local noradrenergic neurotransmission, or vice versa.
There is evidence pointing to the BST as a relay in the
neural circuitry connecting limbic structures that are known
to modulate neuroendocrine responses, such as the medial
40 B R A I N R E S E A R C H 1 3 9 3 ( 2 0 1 1 ) 3 1 – 4 3and central amygdala, hippocampus and medial prefrontal
cortex (Choi et al., 2007; Feldman et al., 1995; Herman and
Cullinan, 1997; Herman et al., 2005; Ulrich-Lai and Herman,
2009). This idea is reinforced by results showing that BST
lesions inhibit amygdala and hippocampus-related neuroen-
docrine responses (Feldman et al., 1990; Zhu et al., 2001). Based
on this, the present results suggest that BST cholinergic
neurotransmission could be an important system in the
neural circuitry of neuroendocrine regulation involved in the
integration to vasopressin systemic release by SON.
In summary, the present results indicate that cardiovas-
cular responses following carbachol microinjection into the
BST are mediated by SON magnocellular neurons, without
significant involvement of those in the PVN. The results also
indicate that responses to the carbachol microinjection into
the BST are mediated by a pathway involving a bilateral SON
cross-talking, possibly through ipsilateral projections from the
BST to the SON and activation of vasopressinergic neurons in
the contralateral SON.4. Experimental procedures
4.1. Animals
Sixty-four male Wistar rats weighing 230–270 g were used.
Animals were kept in the Animal Care Unit of the Department
of Pharmacology of the School of Medicine of Ribeirão Preto,
University of São Paulo. Rats were kept under a 12 h:12 h light–
dark cycle (lights on between 06:00 am and 6:00 pm) and had
free access to water and standard laboratory food. Housing
conditions and experimental procedures were approved by
the University of São Paulo Animal Ethical Committee, which
complies with the Guiding Principles of Research Involving
Animals and Human Beings of the American Physiological
Society.
4.2. Surgical preparation
Four days before the experiment rats were anesthetized with
tribromoethanol (250 mg⁄kg, i.p.). After scalp anesthesia with
2% lidocaine, the skull was exposed and stainless steel guide
cannulae (26 G) were implanted in the BST and in the SON or
PVN, using a stereotaxic apparatus (Stoelting, Wood Dale,
Illinois, USA). Cannulae were positioned 1 mm above injection
sites. Stereotaxic coordinates for cannula implantation in the
BST, PVN or SON were selected according to the rat brain atlas
of Paxinos and Watson (1997). Cannula was implanted
unilaterally in the BST and stereotaxic coordinates were:
anteroposterior: +8.6 mm from the interaural, lateral: 4.0 mm
from the medial suture, ventral: −5.8 mm from the skull, with
a lateral inclination of 23°. Cannulae were implanted in the
ipsilateral or contralateral PVN, in relation to BST cannula, and
stereotaxic coordinates were: anteroposterior: +7.2 mm from
the interaural, lateral: 2 mm from the medial suture, ventral:
−6.9 mm from the skull, with a lateral inclination of 12°.
Cannulae were implanted in the ipsilateral or contralateral
SON, in relation to BST cannula, and stereotaxic coordinates
were: anteroposterior: +6.9 mm from the interaural, lateral:
1.8 mm from the medial suture, ventral: −8.1 mm from theskull. Cannulaewere fixed to the skull with dental cement and
one metal screw. After surgery, the animals received a poly-
antibiotic veterinarian preparation of streptomycins and
penicillins (i.m., 0.27 mg/kg, Pentabiotico®; Fort Dodge, Cam-
pinas, SP, Brazil), to prevent infection, and the nonsteroidal
anti-inflammatory flunixine meglumine (i.m., 0.025 mg/kg,
Banamine®; Schering Plough, Cotia, SP, Brazil), for post-
operative analgesia.
One day before the experiment, animals were anesthetized
with tribromoethanol (250 mg⁄kg, i.p.) and a catheter was
inserted into the abdominal aorta through the femoral artery
for arterial pressure andHR recording. Catheters consisted of a
4 cm piece of PE-10 heat-bound to a 13 cm piece of PE-50 (Clay
Adams, Parsippany, NJ, USA). The catheters were tunneled
under the skin and exteriorized on the animal's dorsum. After
surgery, animals were kept in individual cages, which were
later used for transport to the experimental room. The
nonsteroidal anti-inflammatory flunixine meglumine (i.m.,
0.025 mg⁄kg, Banamine®; Schering Plough, Cotia, SP, Brazil)
was administered for postoperative analgesia.
4.3. Measurement of cardiovascular responses
On the day of the experiment, the arterial cannulas were
connected to a pressure transducer. The pulsatile arterial
pressure (PAP) of freely moving animals was recorded using an
HP-7754A amplifier (Hewlett Packard, Palo Alto, CA, USA) and an
acquisition board (MP100A; Biopac Systems Inc., Goleta, CA,USA)
connected to a computer. Mean arterial pressure (MAP) and HR
values were derived from PAP recordings and processed on-line.
4.4. Drug microinjection in the central nervous system
The needles (33 G; Small Parts, Miami Lakes, FL, USA) used for
microinjection into the BST, SON and PVN were 1 mm longer
than the guide cannulas and were connected to a 2 μL syringe
(7002 KH; Hamilton, Reno, NV, USA) through PE-10 tubing. The
needle was carefully introduced into the guide cannula
without touching or restraining the animal and drugs were
injected in a final volume of 100 nL. After a 20 s period, the
needle was removed.
4.5. Radioimmunoassay
Blood samples were collected in chilled plastic tubes contain-
ing heparin (10 μL of heparin per mL of collected blood).
Samples were centrifuged at 4 °C, 3000 rpm for 20 min. Plasma
vasopressin levels were measured by specific radioimmuno-
assay after previous extraction fromplasmausing acetone and
petroleum ether (Glick and Kagan, 1979; Elias et al., 1997). The
recovery rateswere greater than87%. Theassay sensitivity and
intra- and inter-assay coefficients of variation were 0.9 pg/mL,
4.6 and 18.6%, respectively. All samples from a single
experiment were assayed in duplicate in the same assay.
4.6. Drugs
Carbachol (Sigma, St Louis, MO, USA) and CoCl2 (Sigma) were
dissolved in artificial cerebrospinal fluid (aCSF), with the
following composition: 100 mM NaCl, 2 mM Na3PO4, 2.5 mM
41B R A I N R E S E A R C H 1 3 9 3 ( 2 0 1 1 ) 3 1 – 4 3KCl, 1.0 mM MgCl2, 27 mM NaHCO3 and 2.5 mM CaCl2 (pH 7.4).
Tribomoethanol (Sigma) and urethane (Sigma) were dissolved
in saline (0.9% NaCl). Flunixine meglumine (Banamine®,
Schering Plough, Brazil) and poly-antibiotic preparation of
streptomycins and penicillins (Pentabiotico®, Fort Dodge,
Brazil) were used as provided.
4.7. Experimental protocols
On the day of the experiment, animals were transported to the
experimental room and were allowed 60 min period to adapt
to the experimental room conditions, such as sound and
illumination, before starting arterial pressure and HR record-
ing. The experimental room was acoustically isolated and a
constant background noise was generated by an air exhauster
to minimize sound interference within the experimental
room.
4.7.1. Effect of aCSF or carbachol microinjection into the bed
nucleus of the stria terminalis of unanesthetized rats in plasma
vasopressin levels
This experiment aimed to study the effect of carbachol
microinjection into the BST of unanesthetized rats on plasma
vasopressin levels. For this, two different groups of animals
received vehicle (aCSF, 100 nL, n=6) or carbachol (1 nmol/
100 nL, n=6) injected into the BST (Alves et al., 2007). Five
minutes after BST treatment, animals were decapitated and
blood samples were collected to determine of plasma vaso-
pressin levels.
4.7.2. Effect of supraoptic nucleus pretreatment with aCSF or
CoCl2 on cardiovascular responses to carbachol microinjection
into the bed nucleus of the stria terminalis
These experiments aimed to study the involvement of the
SON in cardiovascular responses to carbachol microinjection
into the BST of unanesthetized rats. For this, animals were
divided into two groups, ipsilateral and contralateral SON
groups. In the ipsilateral SON group, rats had cannulas
implanted unilaterally in the BST and in the ipsilateral SON,
in relation to BST cannula, and were subdivided into vehicle
(aCSF, 100 nL, n=7) and CoCl2 (1 mM/100 nL, n=7) groups
(Busnardo et al., 2007; Crestani et al., 2009a, 2009b; Scopinho et
al., 2008). In the contralateral SON group, rats had cannulas
implanted unilaterally in the BST and in the contralateral SON
and were subdivided into vehicle (aCSF, 100 nL, n=6) and
CoCl2 (1 mM/100 nL, n=6) groups (Alves et al., 2007; Busnardo
et al., 2007; Crestani et al., 2009a, 2009b). Carbachol (1 nmol/
100 nL) was microinjected into the BST on the first day and
again 24 h later, at 10 min after aCSF or CoCl2 microinjection
into the SON (Alves et al., 2007). Different set of animals
received aCSF or CoCl2 into the SON in either ipsilateral or
contralateral SON groups.
4.7.3. Effect of paraventricular nucleus pretreatment with
aCSF or CoCl2 in cardiovascular responses to carbachol
microinjection into the bed nucleus of the stria terminalis
These experiments aimed to study the involvement of the PVN
in cardiovascular responses following carbachol microinjection
into the BST of unanesthetized rats. For this, animals were also
divided in two groups, ipsilateral and contralateral PVN groups.In the ipsilateral PVN group, rats had cannulas implanted
unilaterally in the BST and in the ipsilateral PVN, in relation to
BST cannula, andwere subdivided in vehicle (aCSF, 100 nL, n=7)
andCoCl2 (1 mM/100 nL, n=7) groups (Alves et al., 2007; Crestani
et al., 2009a, 2009b; Scopinho et al., 2008). In the contralateral
PVN group, rats had cannulas implanted unilaterally in the BST
and in the contralateral PVN and were further subdivided in
vehicle (aCSF, 100 nL, n=6) and CoCl2 (1 mM/100 nL, n=6) group
(Alves et al., 2007; Crestani et al., 2009a, 2009b; Scopinho et al.,
2008). Carbachol (1 nmol/100 nL)wasmicroinjected into theBST
on the firstdayandagain24 h later, at 10 minafter aCSForCoCl2
microinjection into the PVN (Alves et al., 2007). Different set of
animals received aCSF or CoCl2 into the PVN in either ipsilateral
PVN or contralateral PVN groups.
4.8. Histological determination of microinjection sites
At the end of the experiment, animals were anesthetized with
urethane (1.25 g⁄ kg i.p.) and 100 nL of 1% Evan's Blue dye was
injected into the BST, SON and PVN as an injection site
marker. Animals were submitted to intracardiac perfusion
with saline (0.9% NaCl) followed by 10% formalin. Brains were
removed and post fixed for 24 h at 4 °C and 40 μm sections
were cut with a cryostat (CM 1900; Leica, Wetzlar, Germany).
Brain sections were stained with 1% neutral red for light
microscopy analysis. The actual placement of the microinjec-
tion needleswas determined according to the rat brain atlas of
Paxinos and Watson (1997).
4.9. Statistical analysis
Data are presented asmean±SEM. ThemaximumMAP andHR
responses to carbachol microinjection into the BST, MAP and
HR basal values and the effect of BST treatment with aCSF or
carbachol in plasma vasopressin levels were compared using
paired Student's t-test. Time-course curves of the MAP and HR
changes caused by carbachol microinjection into the BST
before and after SON or PVN pharmacological manipulation
were compared using two-way ANOVA for repeated measure-
ments (treatment vs. time) with repeated measures on the
second factor. Significance was set at P<0.05.Acknowledgments
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